Summary
The Asia Pacific miRNA Tools and Services Market would witness market growth of 18.3% CAGR during the forecast period (2022-2028).
The growth in the use of miRNA tools and consumables is being assisted by extensive research operations that aim to determine the possible applications of miRNA in the creation of novel therapeutic interventions for various disorders. Understanding the mechanism of action of the signalling pathway is important for the development of miRNA treatment options.
Scientists reported that a specific microRNA aids in maintaining the viability of the endothelium and reduces the likelihood of atherosclerosis. Strong investment in biotechnology firms that provide miRNA treatments is boosting the flow of miRNA research. One of the most important pathologies that affect how mRNA and miRNA interact is cancer.
The genomic areas associated with cancer contain a number of miRNA-targeted cells that are grouped. The translations of mRNAs that encode for oncogenes are frequently repressed by tumor suppressor miRNAs, which prevents the development of tumorigenesis and cancer. As a result, substantial research is being done to discover a therapeutic approach to treating various tumors.
Due to the rising incidence of chronic illnesses and the growing number of research looking into how miRNAs play a role in the onset, progression, and diagnosis of conditions such as cancer, Asia-Pacific offers a large market potential. In 2015, scientists from the National University of Singapore and the Bioprocessing Technology Institute of the Agency for Science, Technology, and Research (A*STAR) developed a non-invasive cancer diagnostics algorithm and miRNA detection technology. MiRNAs are a suitable disease biomarker because the test comprises finding them in a few blood drops, which indicates the presence of malignancies.
The China market dominated the Asia Pacific miRNA Tools and Services Market by Country in 2021; thereby, achieving a market value of $69.6 million by 2028. The Japan market is registering a CAGR of 17.6% during (2022 - 2028). Additionally, The India market would showcase a CAGR of 19.1% during (2022 - 2028).
Based on Technology, the market is segmented into qRT-PCR, Extraction Tools, NGS, Microarray, Functional Analysis Tools and Others. Based on End User, the market is segmented into Research & Academic Institutes, IVD, Pharma & Biotech Companies and CROs. Based on Product & Services, the market is segmented into Research Tools and Services. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include General Electric (GE) Co., Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Illumina, Inc., Qiagen N.V., New England BioLabs, Inc., Promega Corporation, GeneCopoeia and Norgen Biotek Corp.
Scope of the Study
Market Segments covered in the Report:
By Technology
• qRT-PCR
• Extraction Tools
• NGS
• Microarray
• Functional Analysis Tools
• Others
By End User
• Research & Academic Institutes
• IVD, Pharma & Biotech Companies
• CROs
By Product & Services
• Research Tools
• Services
By Country
• China
• Japan
• India
• South Korea
• Singapore
• Malaysia
• Rest of Asia Pacific
Companies Profiled
• General Electric (GE) Co.
• Agilent Technologies, Inc.
• Thermo Fisher Scientific, Inc.
• Bio-Rad Laboratories, Inc.
• Illumina, Inc.
• Qiagen N.V.
• New England BioLabs, Inc.
• Promega Corporation
• GeneCopoeia
• Norgen Biotek Corp.
Unique Offerings
• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free
